Latest News View More>>
Can a Racial Divide Explain Non-Treatment of HCV among the HIV-HCV Coinfected?
BY JENNIFER G. ALLEN
Study finds a common assortment of reasons for non-initiation of HCV therapy, regardless of patient race or ethnicity.
Monitoring Infants for Hepatitis C Virus
BY JENNIFER G. ALLEN
Managing the risk of hepatitis C and liver disease among infants born to mothers with chronic HCV is a challenge.
Chronic Hepatitis C Increases Risk of Death in Patients Admitted to ICU
BY LAUREN SANTYE, ASSISTANT EDITOR
HCV patients with cirrhosis and severe sepsis face elevated risk of organ failure.
Black Plague Reveals Clues for Fighting Hepatitis C
BY LAUREN SANTYE, ASSISTANT EDITOR
Anti-retroviral drug therapy may effectively treat hepatitis C-HIV coinfection.
Keeping Up With Advances in Hepatitis C Treatment
BY JENNIFER G. ALLEN
Antiviral therapies are changing the clinical landscape for the treatment of HCV in developed countries.
Prior Authorization Creates Hurdle in Hepatitis C Treatment
BY JENNIFER G. ALLEN
Patient access to curative hepatitis C medications remains a challenge.
Researchers Examine New Hepatitis C Treatment Models with High Cost Drugs
BY LAUREN SANTYE, ASSISTANT EDITOR
Study predicts when an HCV cure was achieved and predicts when therapy should be discontinued.
Liver Cancer Rates Associated with Hepatitis C Increases
BY CATHERINE KOLONKO
In the US, the incidence of liver cancer rose an average of 2.3% each year overall from 2008 to 2012.
Much Work Needed to Halt Spread of Hepatitis C Worldwide
BY GABRIELLE BENNETT
Next generation sequencing reveals frequent opportunities for exposure to hepatitis C virus in Africa.
Coffee Consumption Found to Reduce Risk of Cirrhosis
BY GABRIELLE BENNETT
Coffee appears to confer a number of protective effects against liver disease.
Features
The Journey to a Cure for Hepatitis C
Michael Sofia, PhD, the inventor of the groundbreaking hepatitis C drug Sovaldi, discusses the research that led to the discovery of the groundbreaking HCV treatment.
In part six, Jim Wilson, RPh, MBA, president of WilsonRx, discusses how hepatitis C impacts the entire body.
BY DAVY JAMES, MANAGING EDITOR
New hepatitis C drugs moved the dream of a cure into a reality that gives patients a new chance at life.
Journals View More>>
Jumping Through Hoops and Over Hurdles
BY DEBORAH BELL
Gaining approval from insurance companies for highly effective new hepatitis C virus treatments is fraught with challenges for patients.
BY ERIC SREDZINSKI, PHARMD, AAHIVP
Patients need to take ownership of their treatment regimen.
BY MICHAEL R. PAGE, PHARMD, RPH
BY CATHERINE GALIOTO
For hepatitis C virus patients coinfected with HIV, the everyday challenges of managing their condition are amplified.
BY MICHAEL R. PAGE, PHARMD, RPH
Long-term damage from the hepatitis C virus is avoidable if you are proactive in seeking help.
BY RANDY DIETRICH
Patients need to take ownership of their fight with hepatitis C.
$auto_registration$